Congratulations to Diana Goode, Ph.D. for receiving the ROI grant for her project, “Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy.”
ROI grants are awarded by the National Institute of Health (NIH) and support research specific to their mission.
Dr. Goode has been involved in the Centers of Biomedical Research Excellence (COBRE) program through the NIH and the award is a testament to her hard work and dedication to the project.